SCHEMBL4757678

SCHEMBL4757678

O=CC1C=CC=CC1(O)OCc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
SLC1A3 P43003 2/20 0.35
SLC1A2 P43004 2/20 0.35
SLC1A1 P43005 2/20 0.35
PDPK1 O15530 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MTOR P42345 1/20 0.35
ALDH1A1 P00352 4/20 0.33
TSHR P16473 2/20 0.33
NR4A1 P22736 1/20 0.33
NR4A2 P43354 1/20 0.33
NR4A3 Q92570 1/20 0.33
HCAR2 Q8TDS4 1/20 0.33
MAPK1 P28482 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19638580 0.87 EPHX2 (0.40) KMT2AMEN1ALDH1A1TSHRL3MBTL1
SCHEMBL5289688 0.79 ALDH1A1 (0.36) KMT2AMEN1SLC1A3SLC1A2SLC1A1
SCHEMBL6710688 0.79 TSHR (0.32) KMT2AMEN1SLC1A3SLC1A2SLC1A1
SCHEMBL5150393 0.76 KMT2A (0.40) KMT2AMEN1SLC1A3SLC1A2SLC1A1
SCHEMBL23748559 0.75 NPC1 (0.33) KMT2AMEN1LMNANPC1MAPT
SCHEMBL31303806 0.72
SCHEMBL17685851 0.71 SLC1A3 (0.37) KMT2AMEN1SLC1A3SLC1A2SLC1A1
SCHEMBL1134295 0.70 MAPT (0.35) KMT2AMEN1ALDH1A1TSHRMAPT
SCHEMBL3416734 0.68 TSHR (0.35) KMT2AMEN1SLC1A3SLC1A2SLC1A1
SCHEMBL5029772 0.67 SLC1A3 (0.37) KMT2AMEN1SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001844-A2 BICYCLIC CARBOXYLIC ACID DERIVATIVES USEFUL FOR TREATING METABOLIC DISORDERS Amgen, Inc (US) 2008-12-17 EP disclosed
WO-2007106469-A2 BICYCLIC CARBOXYLIC ACID DERIVATIVES USEFUL FOR TREATING METABOLIC DISORDERS AMGEN INC. (US) 2007-09-20 WO disclosed